598 related articles for article (PubMed ID: 18536620)
1. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
Panelius J; Lahdenne P; Saxén H; Carlsson SA; Heikkilä T; Peltomaa M; Lauhio A; Seppälä I
J Neurol; 2003 Nov; 250(11):1318-27. PubMed ID: 14648148
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
Panelius J; Sillanpää H; Seppälä I; Sarvas H; Lahdenne P
Scand J Infect Dis; 2007; 39(9):775-80. PubMed ID: 17701715
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
Gooskens J; Templeton KE; Claas EC; van Dam AP
Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
[TBL] [Abstract][Full Text] [Related]
6. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients.
van Burgel ND; Brandenburg A; Gerritsen HJ; Kroes AC; van Dam AP
Clin Microbiol Infect; 2011 Oct; 17(10):1495-500. PubMed ID: 21375653
[TBL] [Abstract][Full Text] [Related]
7. Recombinant or peptide antigens in the serology of Lyme arthritis in children.
Heikkilä T; Huppertz HI; Seppälä I; Sillanpää H; Saxen H; Lahdenne P
J Infect Dis; 2003 Jun; 187(12):1888-94. PubMed ID: 12792865
[TBL] [Abstract][Full Text] [Related]
8. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
Vermeersch P; Resseler S; Nackers E; Lagrou K
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
[TBL] [Abstract][Full Text] [Related]
9. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.
Heikkilä T; Seppälä I; Saxen H; Panelius J; Yrjänäinen H; Lahdenne P
J Clin Microbiol; 2002 Feb; 40(2):453-60. PubMed ID: 11825956
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Int J Infect Dis; 2014 Nov; 28():160-3. PubMed ID: 25316329
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
[TBL] [Abstract][Full Text] [Related]
12. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene.
Schulte-Spechtel U; Fingerle V; Goettner G; Rogge S; Wilske B
Int J Med Microbiol; 2006 May; 296 Suppl 40():250-66. PubMed ID: 16530482
[TBL] [Abstract][Full Text] [Related]
14. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
15. C6-peptide serology as diagnostic tool in neuroborreliosis.
Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
Ledue TB; Collins MF; Young J; Schriefer ME
Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
19. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
[TBL] [Abstract][Full Text] [Related]
20. Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden.
Ornstein K; Berglund J; Bergström S; Norrby R; Barbour AG
Scand J Infect Dis; 2002; 34(5):341-6. PubMed ID: 12069016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
